Table 2.

Median facility-level percentage of patients using calcimimetics by region and facility type, 2018

GeographyFacility TypeNumber of FacilitiesMedian Facility-Level Percentage of Patients Who Are Dialysis Dependent and Using CalcimimeticsInterquartile Range (%)
United StatesLDO52672213
MDO7682217
SDO and other12191820
Midwest Census RegionLDO12642013
MDO1011917
SDO and other3171918
Northeast Census RegionLDO6352515
MDO1281914
SDO and other2291921
South Census RegionLDO25042414
MDO3902417
SDO and other4251925
West Census RegionLDO8641911
MDO1492017
SDO and other2481714
  • Calcimimetic use is defined as having at least 90 d of calcimimetic use, without a gap of no more than 60 d between any consecutive administrations. LDO facilities represent DaVita or Fresenius facilities; MDO facilities represent Dialysis Clinic Inc., US Renal Care, American Renal Associates, and Satellite Healthcare facilities; remainder of facilities are classified as SDO and other. LDO, large dialysis organization; MDO, medium dialysis organization; SDO, small dialysis organization.